Performance History
| Key Stats | |
|---|---|
| Open | $5.29 |
| Prev. Close | $5.28 |
| EPS | -0.48 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $2.01B |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 5.19 | 5.31 |
| 52 Week Range | 4.73 | 9.59 |
| Ratios | |
|---|---|
| P/B Ratio | 1.61 |
| Revenue | $1.05B |
| Operating M. % | -5.55% |
| Earnings | $0.00 |
| Earnings Growth % | 13.59% |
| EBITDA Margin % | -1.93% |
| ROE % | -11.80% |
| EPS | -0.48 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
Correlated Companies
About LifeStance Health Group (LFST)
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- CEO
- Mr. Kenneth Alan Burdick
- Headquarters
- Scottsdale
- Employees
- 6132
- Exchange
- NASDAQ
Keep an eye on LifeStance Health Group
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
What is LifeStance Health Group's (LFST) price per share?
The current price per share for LifeStance Health Group (LFST) is $5.29. The stock has seen a price change of $0.01 recently, indicating a 0.19% change. This reflects the stock's recent market performance and investor sentiment.
What is the 52-week high and low for LifeStance Health Group (LFST)?
For LifeStance Health Group (LFST), the 52-week high is $9.59, which is 81.29% from the current price. The 52-week low is $4.74, the current price is 11.72% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
Is LifeStance Health Group (LFST) a growth stock?
LifeStance Health Group (LFST) has shown an average price growth of 0.41% over the past three years. It has received a score of 28 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying LifeStance Health Group as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
What is LifeStance Health Group (LFST) stock price performance year to date (YTD)?
As of the latest data, LifeStance Health Group (LFST) has a year-to-date price change of -33.04%. Over the past month, the stock has experienced a price change of -29.28%. Over the last three months, the change has been -12.99%. Over the past six months, the figure is -30.39%.
Is LifeStance Health Group (LFST) a profitable company?
LifeStance Health Group (LFST) has a net income of -$186.26M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 21% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -5.55% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.06B, with a revenue growth rate of 22.82%, providing insight into the company's sales performance and growth. The gross profit is $221.66M. Operating income is noted at -$187.35M. Furthermore, the EBITDA is -$20.37M.
What is the market capitalization of LifeStance Health Group (LFST)?
LifeStance Health Group (LFST) has a market capitalization of $2.02B. The average daily trading volume is 1.17M, indicating the stock's liquidity and investor engagement.
News
Down -8.97% in 4 Weeks, Here's Why You Should You Buy the Dip in LifeStance Health (LFST)
Mikra Completes Design of New Product and Advances Shipment Date
LifeStance to Participate in Upcoming Investor Conferences
LifeStance Health Group Announces Pricing of Secondary Public Offering
LifeStance Health Group Announces Launch of Secondary Public Offering
Lifeist Announces TSXV Approval of Common Share Consolidation
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.